SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-10-001428
Filing Date
2010-12-02
Accepted
2010-12-01 18:03:10
Documents
9
Period of Report
2010-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 15062
2 NEWS RELEASE DATED DECEMBER 1, 2010 ex991.htm EX-99.1 10406
3 MATERIAL CHANGE REPORT ex992.htm EX-99.2 25003
4 MATERIAL CONTRACT ex993.htm EX-99.3 194443
5 LOGO loruslogo.jpg GRAPHIC 11681
6 GRAPHIC graph1.jpg GRAPHIC 49776
7 GRAPHIC graph2.jpg GRAPHIC 74929
8 GRAPHIC graph3.jpg GRAPHIC 37332
9 GRAPH graph4.jpg GRAPHIC 20160
  Complete submission text file 0001279569-10-001428.txt   514356
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 101225782
SIC: 2836 Biological Products, (No Diagnostic Substances)